Cannabics Pharmaceuticals

About:

Cannabics Pharmaceuticals is dedicated to the development of Personalized Anti-Cancer treatments.

Website: http://www.cannabics.com

Twitter/X: cannabics1

Description:

Cannabics Pharmaceuticals (CNBX), a U.S based company, is dedicated to the development of Palliative and personalized Anti-Cancer treatments. The Company's scientific focus is on harnessing the therapeutic properties of natural Cannabinoids. Cannabics' vision is to create tailored therapies for cancer patients, utilizing advanced screening systems and bioinformatic tools. The Company's R&D is based in Israel, where it is licensed by the Ministry of Health and involves both scientific and academic research as well as current medical clinical studies

Total Funding Amount:

$3M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Bethesda, Maryland, United States

Founded Date:

2012-03-21

Contact Email:

info(AT)cannabics.com

Founders:

Eyal Ballan, Itamar Borochov

Number of Employees:

1-10

Last Funding Date:

2017-05-06

IPO Status:

Public

Industries:

© 2025 bioDAO.ai